-
TAKEDA PHARMACEUTICAL COMPANY LTD. et al v. TORRENT PHARMACEUTICALS LTD. et al DC CAFC
- 2:17-cv-03186
- D.N.J.
- Judge: Stanley R. Chesler
+1
- Filed: 05/05/2017
- Closed: 02/13/2020
- Latest Docket Entry: 03/31/2021
- PACER
- Docket updated daily
4
Plaintiffs
2
Defendants
4
Accused
Products
4
Patents-in-Suit
1,015
Days in
Litigation
-
TAKEDA PHARMACEUTICAL COMPANY LTD. et al v. TORRENT PHARMACEUTICALS LTD. et al DC CAFC
- 2:17-cv-03186
- D.N.J.
- Judge: Stanley R. Chesler
+1
- Filed: 05/05/2017
- Closed: 02/13/2020
- Latest Docket Entry: 03/31/2021
- PACER
- Docket updated daily
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
| Claim # | Claim Text | Outcome |
|---|---|---|
| 4 |
A compound of the formula</claim-text> <chemistry id="CHEM-US-00065" num="00065"><img id="EMI-C00065" he="35.81mm" wi="42.84mm" file="US07807689-20101005-C00065.TIF" alt="embedded image" img-content="chem" img-format="tif"/></chemistry> or
view more
|
Valid
Entry 130 |
| 12 |
A compound of the formula</claim-text> <chemistry id="CHEM-US-00069" num="00069"><img id="EMI-C00069" he="35.81mm" wi="42.84mm" file="US07807689-20101005-C00069.TIF" alt="embedded image" img-content="chem" img-format="tif"/></chemistry> wherein the
view more
|
Valid
Entry 130 |
-
Infringement
Torrent Pharmaceuticals Limited
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 6.25 mg, 12.5 mg, 25 mg oral tablets containing alogliptin benzoatecombination 12.5 mg of alogliptin benzoate and 500 mg/1000 mg metformin hydrochloridecombination of 12.5 mg/25 mg alogliptin benzoate and 15 mg/30 mg/45 mg pioglitazoneOral tablets containing a combination of 12.5 mg alogliptin benzoate and 500 mg/1000 mg metformin hydrochloride | US 7,807,689 B2 |
4, 12
|
Infringement
Entry 130
|
Torrent Pharma Incorporated
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 6.25 mg, 12.5 mg, 25 mg oral tablets containing alogliptin benzoatecombination 12.5 mg of alogliptin benzoate and 500 mg/1000 mg metformin hydrochloridecombination of 12.5 mg/25 mg alogliptin benzoate and 15 mg/30 mg/45 mg pioglitazoneOral tablets containing a combination of 12.5 mg alogliptin benzoate and 500 mg/1000 mg metformin hydrochloride | US 7,807,689 B2 |
4, 12
|
Infringement
Entry 130
|
